Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-06-06
1998-12-01
Saunders, David
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
424 149, 424 934, 424 94, 4241331, 435 696, 4351723, 5303873, 5303911, 5303913, 530391, A61K 39395, V07K 1630, G01N 33574
Patent
active
058436855
ABSTRACT:
The invention is directed to a chimeric immunoglobulin that recognizes the human tumor antigen bound by antibody ING-1, its production, and use.
REFERENCES:
patent: 4354847 (1982-10-01), Liu et al.
patent: 4612282 (1986-09-01), Schlom et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4818709 (1989-04-01), Primus et al.
patent: 5500362 (1996-03-01), Robinson et al.
Choo, K.H. et al., "Vectors for Expession and Amplification of cDNA in Mammalian Cells: Expression of Rat Phenylalanine Hydroxylase,K" DNA 5(6) :529537 (1986).
Dillman, R.O., "Monoclonal Antibodies for Treating Cancer," Annals Internal Medicine 111(7):592-603 (Oct. 1989).
Harris, W.J. et al., "Therapeutic antibodies-the coming of age," Trends in Biotech. 11:42-44 (Feb. 1993).
Hay, R. et al., eds., in: American Type Culture Collection Catalogue of Cell Lines and Hybridomas Seventh Edition, 1992, p. 381: ATCC Hybridoma 8110 (Jan. 1992).
Hird, V. et al., "Immunotherapy with Monoclonal Antibodies," in: Genes and Cancer, Carney, D and Sikora, K., eds., John Wiley & Sons Ltd. pp. 183-189 (Oct. 1990).
Liu, A.Y. et al., "Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells," Proc. Natl. Acad. Sci. USA 84:3439-3443 (May 1987).
Liu, A.Y. et al., "Production Of a Mouse-Human Chimeric Monoclonal Antibody To CD20 With Potent Fc-Dependent Biologic Activity," The Journal of Immunology 139(10):3521-3526 (Nov. 1987).
Nose, M. and H. Wigzell, "Biological significance of carbohydrate chains on monoclonal antibodies," Proc. Natl. Acad. Sci. USA 80:6632-6636 (1983).
Okayama, H. et al., "A cDNA Cloning Vector That Permits Expression of cDNA Inserts in Mammalian Cells," Molecular and Cellular Biology 3(2) :280-289 (1983).
Oldham, R.K. et al., "Adriamycin custom-tailored immunoconjugates in the treat of human maliganancies," Mol. Biother. 1(2):103-113 (Jun. 1988).
Robinson, R.R. et al., "Chimeric mouse-human anti-carcinoma antibodies that mediate different anti-tumor cell biological activities," Hum. Antibod. Hybridomas 2:84-93 (Apr. 1991).
Sasada, R. et al., "The Establishment of IL-2 Producing Cells by Genetic Engineering," Cell Structure and Function 12:205-217 (Apr. 1987).
Shaw, D.R. et al., "Mouse/Human Chimeric Antibodies to a Tumor-Associated Antigen: Biologic Activity of the Four Human IgG Subclasses," Journal of the National Cancer Institute 80(19):1553-1559 (Dec. 1988).
Steplewski, Z. et al., "Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity," Proc. Natl. Acad. Sci. USA 85:4852-4856 (Jul. 1988).
Wawrzynczak, E.J. et al., "Strategies in antibody therapy of cancer," Clin. exp. Immunol. 82:189-193 (Oct. 1990).
Whittle, N. et al., "Expression in COS cells of a mouse-human chimaeric B72.3 antibody," Protein Engineering 1(6):499-505 (Dec. 1987).
S.-K. Liao et al, JNCI, 74, 1047-1057, 1985.
Y. Nishimura et al, Cancer Res. 47, 999-1005, 1987.
Barr, Ian G. Ph.D. et al., "Retargeting of Cytolytic T Lymphocytes by Heteroaggregated (Bispecific) Antibodies," Cancer Detection and Prevention. Prev. 12:439-450 (1988).
Gillies, Stephen D. et al., "Expression of Genetically Engineered Immunoconjugates of Lymphotoxin and a Chimeric Anti-Ganglioside GD2 Antibody," Hybridoma 10(3):347-356, Jan. 7, 1991.
Mujoo, Kalpana et al., "A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD.sub.2," Cancer Immunology Immunotherapy 34:198-204, Jul. 23, 1991.
Better Marc D.
Chang Changtung Paul
Horwitz Arnold H.
Lei Shau-Ping
Robinson Randy R.
Saunders David
Xoma Corporation
LandOfFree
Production of chimeric mouse-human antibodies with specificity t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of chimeric mouse-human antibodies with specificity t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of chimeric mouse-human antibodies with specificity t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2394776